tiprankstipranks
Trending News
More News >

Nancy Lynn MD Snyderman Insider Profile

4 Followers
Nancy Lynn MD Snyderman, Director at Alkermes, holds 31.51K shares in Alkermes (Ticker: ALKS), holds 0.00 shares in Axonics Modulation Technologies (Ticker: AXNX), holds 1.02K shares in Lyra Therapeutics (Ticker: LYRA).
tipranks
Nancy Lynn MD Snyderman

Nancy Lynn MD Snyderman
Alkermes (ALKS)
Director

Ranked #74,827 out of 106,487 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-17.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$888K
99.94%
0.06%
A breakdown of Nancy Lynn MD Snyderman's holdings

Insider Roles

Alkermes
(ALKS)
Director
Lyra Therapeutics
(LYRA)
Director
Roles that Nancy Lynn MD Snyderman holds in companies

Most Profitable Insider Trade

Stock:
Alkermes
(ALKS)
Rating:Informative Buy
Date:Mar 08, 2022 - Mar 08, 2023
Return:+12.40%
The most profitable trade made by Nancy Lynn MD Snyderman

Nancy Lynn MD Snyderman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Alkermes
Jun 02, 2025
Director
Uninformative Buy
186.38K
$887.03K
AXNX
Axonics Modulation Technologies
Nov 15, 2024
Uninformative Sell
1.06M
$0.00
Lyra Therapeutics
Dec 17, 2020
Director
Informative Buy
9.96K
$502.25
List of latest transactions for each holding click on a transaction to see Nancy Lynn MD Snyderman's performance on stock

Nancy Lynn MD Snyderman insider profile FAQ

What is the percentage of profitable transactions made by Nancy Lynn MD Snyderman?
The percentage of profitable transactions made by Nancy Lynn MD Snyderman is 33%.
    What is the average return per transaction made by Nancy Lynn MD Snyderman?
    The average return per transaction made by Nancy Lynn MD Snyderman is -17.40%.
      What stocks does Nancy Lynn MD Snyderman hold?
      Nancy Lynn MD Snyderman holds: ALKS, AXNX, LYRA stocks.
        What was Nancy Lynn MD Snyderman’s latest transaction?
        Nancy Lynn MD Snyderman latest transaction was an Uninformative Buy of $186.38K.
          What was Nancy Lynn MD Snyderman's most profitable transaction?
          Nancy Lynn MD Snyderman’s most profitable transaction was an Informative Buy of ALKS stock on March 8, 2022. The return on the trade was 12.40%.
            What is Nancy Lynn MD Snyderman's role in Alkermes?
            Nancy Lynn MD Snyderman's role in Alkermes is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.